A Challenging Case of Severe Ulcerative Colitis following the Initiation of Secukinumab for Ankylosing Spondylitis

Secukinumab is an interleukin-17 inhibitor used for the treatment of ankylosing spondylitis (AS), psoriasis, and psoriatic arthritis. The risk of exacerbating underlying inflammatory bowel disease (IBD) in patients being treated with secukinumab for other conditions is controversial. We document a p...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Case Rep Gastrointest Med
Asıl Yazarlar: Ehrlich, Dean, Jamaluddin, Nimah, Pisegna, Joseph, Padua, David
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi 2018
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5832071/
https://ncbi.nlm.nih.gov/pubmed/29666723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9679287
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller